T. Rowe Price Associates »

Janux Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.2M 159k 45.43
2024-06-30 $11M 252k 41.89
2024-03-31 $738k 20k 37.68

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics